Evidence map›Paper›PMID 30835071›Full record

ArticleEnvironmental science and pollution research international2019

Sulforaphane potentially attenuates arsenic-induced nephrotoxicity via the PI3K/Akt/Nrf2 pathway in albino Wistar rats.

Shanmugam Thangapandiyan, Mathan Ramesh, Selvaraj Miltonprabu, Tamilselvan Hema, Gunasekaran Bavithra Jothi, Venkatesan Nandhini

RetractedOpen access · hybridAbstract readRetracted Publication
In one paragraph

Article in Environmental science and pollution research international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. The Role of Toxic Metals and Metalloids in Nrf2 Signaling.Antioxidants (Basel, Switzerland) · 2021
    Review
  12. Article
  13. Review
  14. TUNEL Assay: A Powerful Tool for Kidney Injury Evaluation.International journal of molecular sciences · 2021
    Review
  15. Article
  16. Phytoremedial effect of Tinospora cordifolia against arsenic induced toxicity in Charles Foster rats.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2020
    Article
  17. Genome-Protecting Compounds as Potential Geroprotectors.International journal of molecular sciences · 2020
    Review
  18. Article
  19. Filtering through the role of NRF2 in kidney disease.Archives of pharmacal research · 2020
    Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Shanmugam ThangapandiyanN-PDF, Unit of Toxicology, Department of Zoology, Bharathiar University, Coimbatore, Tamilnadu, 641064, India. s.thangapandiyanphd@gmail.com.ORCID http://orcid.org/0000-0003-3958-9169
Mathan RameshUnit of Toxicology, Department of Zoology, Bharathiar University, Coimbatore, Tamilnadu, 641 046, India.
Selvaraj MiltonprabuDepartment of Zoology, University of Madras, Chennai, Tamilnadu, 600025, India.
Tamilselvan HemaUnit of Toxicology, Department of Zoology, Bharathiar University, Coimbatore, Tamilnadu, 641 046, India.
Gunasekaran Bavithra JothiUnit of Toxicology, Department of Zoology, Bharathiar University, Coimbatore, Tamilnadu, 641 046, India.
Venkatesan NandhiniUnit of Toxicology, Department of Zoology, Bharathiar University, Coimbatore, Tamilnadu, 641 046, India.
Bharathiar University · INUniversity of Madras · IN

Funding

Department of Science and Technology, India PDF/2016/003063
6 · The paper itself

Abstract

Oxidative stress plays a significant role in the pathophysiology of numerous kidney diseases, generally mediated by reactive oxygen species (ROS). Arsenic (Ar) is known to exert its toxicity through the generation of ROS and inflammation. The current study investigates the protective effects of sulforaphane (SFN) against arsenic-induced renal damage via PI3K/Akt-mediated Nrf2 pathway signaling. Thirty-two male albino Wistar rats were randomly divided into four groups of eight animals each, designated as control, arsenic (Ar), sulforaphane plus Ar (SFN+Ar), and sulforaphane alone (SFN), with oral administration of Ar (5 mg/kg BW) and SFN (80 mg/kg BW) daily for 28 days. Ar administration significantly (P < 0.05) increased the levels of ROS, OHdG, Ar accumulation, and lipid peroxidation, and decreased levels of enzymatic and nonenzymatic antioxidants. Notably, a significant (P < 0.05) increase was observed in markers of apoptosis, DNA damage, TUNEL-positive cells, and dark staining of ICAM-1 in renal tissue with decreased PI3K/Akt/Nrf2 gene expression. The biochemical findings were supported by histopathological and electron microscopy evaluation, which showed severe renal damage in rats treated with Ar. Pretreatment with SFN significantly (P < 0.05) attenuated renal ROS, OHdG, lipid peroxidation, and DNA damage, and increased phase II antioxidants via PI3K/Akt-mediated Nrf2 activation in renal tissue. These results show that dietary supplementation with SFN protects against Ar-induced nephrotoxicity via the PI3K/Akt-mediated Nrf2 signaling pathway in the rat kidney.

Indexed as

ArsenicHazardous SubstancesIsothiocyanatesProtective AgentsAnimalsAntioxidantsApoptosisKidneyLipid PeroxidationMaleNF-E2-Related Factor 2Oxidative StressPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRatsRats, WistarAntioxidantsArsenicHazardous SubstancesIsothiocyanatesNF-E2-Related Factor 2Phosphatidylinositol 3-KinasesProtective AgentsProto-Oncogene Proteins c-aktReactive Oxygen SpeciessulforaphaneSulfoxidesArsenicNephrotoxicityNrf2 pathwayPI3K/AktRatSulforaphane

Identifiers

PMID30835071
PMCPMC6476857
OpenAlexW2919658072

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.